Stanford University, officially Leland Stanford Junior University, is a private research university located in the census-designated place of Stanford, California, near the city of Palo Alto. The campus occupies 8,180 acres, among the largest in the United States, and enrolls over 17,000 students.

During the past decade, Stanford conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stanford" #1 sponsor was "Stanford University" with 7 trials, followed by "AIDS Clinical Trials Group" with 1 trials sponsored, "Aerpio Therapeutics" with 1 trials sponsored, "Allergan" with 1 trials sponsored and "Beckman Coulter, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "ConvaTec Inc." with 1 trials as a collaborator, "Cystic Fibrosis Foundation" with 1 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Medtronic" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Stanford" are "Diabetes Mellitus" (2 trials), "Parkinson Disease" (2 trials), "Anti-Mullerian Hormone" (1 trials), "Arterial Occlusive Diseases" (1 trials) and "Arteriosclerosis" (1 trials). Many other conditions were trialed in "Stanford" in a lesser frequency.

Most popular intervention types in "Stanford" are "Device" (5 trials), "Drug" (5 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "0.67% Sodium Chloride Ophthalmic Solution" (1 trials), "AKB-9778" (1 trials), "Access AMH Assay" (1 trials) and "Ataluren" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stanford" are 17 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Stanford". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Stanford, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Stanford, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".